Cell Impact AB (publ) manufactures and sells bipolar flow plates for hydrogen fuel cells and electrolyzers in the United States, Sweden, Other Europe, and Asia. The company provides production series of flow plates; design for manufacturing and other design services; tools and prototypes; local production; and leak testing, cleaning options, and advanced measurement instruments. The company was incorporated in 1999 and is headquartered in Karlskoga, Sweden.…
Cell Impact to evaluate NC titanium for undisclosed customers
Cell Impact (STO: CI) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Metal Fabrication industry, part of the Industrials sector, and reports about 26 employees.
The shares were at 0.0168 SEK on 20 November 2026, down 96.1% over 52 weeks. Its 52-week range is 0.0105 SEK to 0.4580 SEK: the price is 96.3% below the high and 60.0% above the low.
Its market capitalisation is 22.29M SEK.
Cell Impact reports return on equity of -109.1% and revenue up 95.0% year over year.
It holds more cash than debt, a net cash position of 2.75M SEK. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health.
No upcoming events tracked.